Details for Patent: 10,925,832
✉ Email this page to a colleague
Which drugs does patent 10,925,832 protect, and when does it expire?
Patent 10,925,832 protects COBENFY and is included in one NDA.
This patent has twenty-nine patent family members in eighteen countries.
Drugs Protected by US Patent 10,925,832
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-myers | COBENFY | trospium chloride; xanomeline tartrate | CAPSULE;ORAL | 216158-001 | Sep 26, 2024 | RX | Yes | No | 10,925,832 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Bristol-myers | COBENFY | trospium chloride; xanomeline tartrate | CAPSULE;ORAL | 216158-002 | Sep 26, 2024 | RX | Yes | No | 10,925,832 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Bristol-myers | COBENFY | trospium chloride; xanomeline tartrate | CAPSULE;ORAL | 216158-003 | Sep 26, 2024 | RX | Yes | Yes | 10,925,832 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,925,832
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019346626 | ⤷ Subscribe | |||
| Australia | 2022224813 | ⤷ Subscribe | |||
| Brazil | 112021005802 | ⤷ Subscribe | |||
| Canada | 3114623 | ⤷ Subscribe | |||
| Canada | 3180743 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
